ENDONOVO THERAPEUTICS, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
ENDONOVO THERAPEUTICS, INC. (ENDV) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $646.91 thousand as of 2022-09-30, per its 10-Q filed 2022-11-21.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2022-11-21
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $646.91K.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $646.91K.
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $646.91K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2022-09-30 | $646.91K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $646.91K 10-Q · filed 2022-08-22 |
| 2022-03-31 | $646.91K 10-Q · filed 2022-05-19 |